
Pais Biotech India Private Limited
About Pais Biotech India Private Limited
Data last updated:
Pais Biotech India Private Limited is a private limited company based in Ahmednagar, Maharashtra, India. It operates in the agriculture and horticulture segment of the agriculture sector. It was incorporated on 21 March 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U01100PN2017PTC169504. Its GSTIN is 27AAJCP0709M1Z5 (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Bhagirath Ramrao Jadhav and Viraj Bhagirath Jadhav.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Indiranagar Tal Shrirampur, Ahmednagar, Maharashtra, India – 413709.
As per the financials filed for FY 2024, the company reported a revenue of ₹14.61 Lakh. For the same year it recorded a net loss of ₹1.12 Lakh (net margin -7.7%) and EBITDA of ₹5.11 Lakh (EBITDA margin 35%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years.
As per MCA filings, the company has open charges of ₹26.25 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Pais Biotech India Private Limited's registered office is in Ahmednagar, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressIndiranagar Tal Shrirampur, Ahmednagar, Maharashtra, India – 413709
- IndustryAgriculture, Horticulture, Market Gardening
To see the full contact details of Pais Biotech India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Pais Biotech India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Pais Biotech India Private Limited, buy the company report.
Financials of Pais Biotech India Private Limited
FY 2025 filings availablePais Biotech India Private Limited reported revenue of ₹14.61 Lakh for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 19% over three years. EBITDA fell 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.11 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.12 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 35% | ||||
| Net Profit Margin | -7.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Pais Biotech India Private Limited, buy the company report.
Board of directors of Pais Biotech India Private Limited
Pais Biotech India has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhagirath Ramrao Jadhav | Director | 21 Mar 2017 | 9 Years 7 Months | Current |
| Viraj Bhagirath Jadhav | Director | 21 Mar 2017 | 9 Years 7 Months | Current |
| Shanta Bhagirath Jadhav | Director | 11 Apr 2017 | 9 Years 7 Months | Current |
| Trupti Vishal Jadhav | Director | 11 Apr 2017 | 9 Years 7 Months | Current |
Peer comparison
Pais Biotech India Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Alliance Molecules Private Limited | ₹14.67 Lakh (FY 2020) | Hyderabad, Telangana, India | ||||
| Nakshathra Medi Science Private Limited | ₹14.67 Lakh (FY 2023) | -86.0% | Chennai, Tamil Nadu, India | |||
| MD Instruments and Controls Private Limited | ₹14.64 Lakh (FY 2019) | Sonarpada, Dombivali (E), Maharashtra, India | ||||
| Celer Crop Care Private Limited | ₹14.63 Lakh (FY 2024) | -38.0% | Coimbatore, Tamil Nadu, India | |||
| Sol Life Sciences India Private Limited | ₹14.62 Lakh (FY 2024) | -2.0% | Gwalior, Madhya Pradesh, India | |||
| Pais Biotech India Private Limitedthis company | ₹14.61 Lakh (FY 2024) | -₹1.12 Lakh | -7.7% | Ahmednagar, Maharashtra, India | ||
| Red Moon Labs Private Limited | ₹14.6 Lakh (FY 2018) | 214.0% | Ghaziabad, Uttar Pradesh, India | |||
| Praval Pharmaceuticals Private Limited | ₹14.59 Lakh (FY 2025) | -7.0% | Chennai, Tamil Nadu, India | |||
| Ateen Nutrients Private Limited | ₹14.59 Lakh (FY 2024) | -35.0% | Ludhiana, Punjab, India | |||
| Linum Life Science Private Limited | ₹14.58 Lakh (FY 2021) | 38.0% | Cuttack, Odisha, India | |||
| Battle Force Facilities Private Limited | ₹14.55 Lakh (FY 2024) | -20.0% | Bhor, Maharashtra, India |
To see the full peer comparison of Pais Biotech India Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Oct 2019 | 100298719 | Canara Bank | ₹26.25 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Pais Biotech India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Pais Biotech India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Pais Biotech India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAJCP0709M1Z5 | Maharashtra | Active | 12 Jun 2019 |
To see the full GST registrations and return filing status of Pais Biotech India Private Limited, buy the company report.
Recent activity
Pais Biotech India Private Limited has 5 board changes on record since 2017: 4 appointments and 1 cessation. The latest: Vishal Bhagirath Jadhav ceased to be Director on 01 Jan 2020.
Frequently asked questions
Pais Biotech India is an active private limited company based in Ahmednagar, Maharashtra, India. The company works in horticulture, within the agriculture industry. It was incorporated on 21 March 2017 (9+ years old) and is registered under CIN U01100PN2017PTC169504.
Pais Biotech India has 4 current directors:
- Bhagirath Ramrao Jadhav - Director
- Viraj Bhagirath Jadhav - Director
- Shanta Bhagirath Jadhav - Director
- Trupti Vishal Jadhav - Director
The latest financial statements of Pais Biotech India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Pais Biotech India is 27AAJCP0709M1Z5, registered in Maharashtra.
The CIN (Corporate Identification Number) of Pais Biotech India is U01100PN2017PTC169504. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pais Biotech India was incorporated on 21 March 2017, making it 9+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Pais Biotech India by revenue are Alliance Molecules Private Limited, Nakshathra Medi Science Private Limited, MD Instruments and Controls Private Limited, Celer Crop Care Private Limited, Sol Life Sciences India Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Vishal Bhagirath Jadhav ceased to be Director on 01 Jan 2020. Shanta Bhagirath Jadhav was appointed as Director on 11 Apr 2017. Trupti Vishal Jadhav was appointed as Director on 11 Apr 2017. Pais Biotech India has 5 board changes on record in total.
The registered office of Pais Biotech India is at Indiranagar Tal Shrirampur, Ahmednagar, Maharashtra, India – 413709.
Pais Biotech India operates in the agriculture industry, in the horticulture segment.
Pais Biotech India has open charges of ₹26.25 Lakh and no satisfied charges on record as per latest MCA filings.

